Home › Rhabdomyosarcoma › Utah › Salt Lake City
Rhabdomyosarcoma clinical trials in Salt Lake City, UT
4 studies for Rhabdomyosarcoma are looking for participants at sites in and around Salt Lake City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RecruitingPhase 1/2
- Primary Children's Hospital, Salt Lake City
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
RecruitingPhase 3
- Primary Children's Hospital, Salt Lake City
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
RecruitingPhase 1/2
- University of Utah Hospital, Salt Lake City
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
RecruitingPhase 2
- Primary Children's Hospital, Salt Lake City
Rhabdomyosarcoma trials in other cities
- Houston, TX6 studies
- Memphis, TN6 studies
- Washington, DC5 studies
- Boston, MA4 studies
- Philadelphia, PA4 studies
- Seattle, WA3 studies
- Dallas, TX3 studies
- Birmingham, AL3 studies
- The Bronx, NY3 studies
- Baltimore, MD3 studies
- Aurora, CO3 studies
Other studies in Salt Lake City
- Non-Small Cell Lung Cancer31 studies
- Cancer (all types)27 studies
- Breast Cancer27 studies
- Colorectal Cancer22 studies
- Lung Cancer21 studies
- Melanoma21 studies
- Multiple Myeloma21 studies
- Metastatic Cancer20 studies
- Ovarian Cancer19 studies
- Obesity18 studies
- Acute Myeloid Leukemia17 studies
- Heart Failure17 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.